Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd announced that its subsidiary, OxiDx Pty Ltd, has secured a new patent in China for its OxiDx technology, which measures oxidative stress using a simple fingerprick blood sample. This patent, valid until 2039, extends the company’s intellectual property protection across major markets including the USA, Japan, Europe, China, and Australia. The OxiDx test, which is gaining traction in sectors such as high-performance sports and horse racing, is crucial as oxidative stress is linked to over 70 health conditions, including muscle injuries prevalent in these industries.
The most recent analyst rating on (AU:PIQ) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a leading medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, which involves the large-scale study of proteins’ structure and function, aiming to enhance disease treatment through innovative tools.
Average Trading Volume: 129,971
Technical Sentiment Signal: Sell
Current Market Cap: A$51.76M
Learn more about PIQ stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue